141 related articles for article (PubMed ID: 16322684)
1. The role of relaxin in endometrial cancer.
Kamat AA; Feng S; Agoulnik IU; Kheradmand F; Bogatcheva NV; Coffey D; Sood AK; Agoulnik AI
Cancer Biol Ther; 2006 Jan; 5(1):71-7. PubMed ID: 16322684
[TBL] [Abstract][Full Text] [Related]
2. Relaxin 2/RXFP1 Signaling Induces Cell Invasion via the β-Catenin Pathway in Endometrial Cancer.
Fue M; Miki Y; Takagi K; Hashimoto C; Yaegashi N; Suzuki T; Ito K
Int J Mol Sci; 2018 Aug; 19(8):. PubMed ID: 30126180
[TBL] [Abstract][Full Text] [Related]
3. Relaxin promotes prostate cancer progression.
Feng S; Agoulnik IU; Bogatcheva NV; Kamat AA; Kwabi-Addo B; Li R; Ayala G; Ittmann MM; Agoulnik AI
Clin Cancer Res; 2007 Mar; 13(6):1695-702. PubMed ID: 17363522
[TBL] [Abstract][Full Text] [Related]
4. Matrix metalloproteinases 2 and 9, E-cadherin, and beta-catenin expression in endometriosis, low-grade endometrial carcinoma and non-neoplastic eutopic endometrium.
Shaco-Levy R; Sharabi S; Benharroch D; Piura B; Sion-Vardy N
Eur J Obstet Gynecol Reprod Biol; 2008 Aug; 139(2):226-32. PubMed ID: 18295959
[TBL] [Abstract][Full Text] [Related]
5. [Preliminary investigation of the expression and functions of insulin receptor isoforms in endometrial carcinoma].
Zhang G; Li XP; Wang JL; Wei LH
Zhonghua Fu Chan Ke Za Zhi; 2012 Nov; 47(11):839-45. PubMed ID: 23302125
[TBL] [Abstract][Full Text] [Related]
6. ROR1 and ROR2 play distinct and opposing roles in endometrial cancer.
Henry CE; Llamosas E; Daniels B; Coopes A; Tang K; Ford CE
Gynecol Oncol; 2018 Mar; 148(3):576-584. PubMed ID: 29395309
[TBL] [Abstract][Full Text] [Related]
7. Functional implications of the utero-placental relaxin (RLN) system in the dog throughout pregnancy and at term.
Nowak M; Gram A; Boos A; Aslan S; Ay SS; Önyay F; Kowalewski MP
Reproduction; 2017 Oct; 154(4):415-431. PubMed ID: 28667126
[TBL] [Abstract][Full Text] [Related]
8. Golgi phosphoprotein 3 (GOLPH3) promotes endometrial carcinoma cell invasion and migration by regulating the epithelial-mesenchymal transition.
Wen Y; Tan X; Wu X; Wu Q; Qin Y; Liang M; Ran G; Gu H; Xie R
Cancer Biomark; 2019; 26(1):21-30. PubMed ID: 31322544
[TBL] [Abstract][Full Text] [Related]
9. Lysophosphatidic acid (LPA) effects on endometrial carcinoma in vitro proliferation, invasion, and matrix metalloproteinase activity.
Wang FQ; Ariztia EV; Boyd LR; Horton FR; Smicun Y; Hetherington JA; Smith PJ; Fishman DA
Gynecol Oncol; 2010 Apr; 117(1):88-95. PubMed ID: 20056268
[TBL] [Abstract][Full Text] [Related]
10. Relaxin-3: improved synthesis strategy and demonstration of its high-affinity interaction with the relaxin receptor LGR7 both in vitro and in vivo.
Bathgate RA; Lin F; Hanson NF; Otvos L; Guidolin A; Giannakis C; Bastiras S; Layfield SL; Ferraro T; Ma S; Zhao C; Gundlach AL; Samuel CS; Tregear GW; Wade JD
Biochemistry; 2006 Jan; 45(3):1043-53. PubMed ID: 16411781
[TBL] [Abstract][Full Text] [Related]
11. A common effect of angiotensin II and relaxin 2 on the PNT1A normal prostate epithelial cell line.
Domińska K; Ochędalski T; Kowalska K; Matysiak-Burzyńska ZE; Płuciennik E; Piastowska-Ciesielska AW
J Physiol Biochem; 2016 Sep; 72(3):381-92. PubMed ID: 27119161
[TBL] [Abstract][Full Text] [Related]
12. Expression of matrix metalloproteinase-26 and tissue inhibitors of metalloproteinases TIMP-3 and -4 in benign endometrium and endometrial cancer.
Tunuguntla R; Ripley D; Sang QX; Chegini N
Gynecol Oncol; 2003 Jun; 89(3):453-9. PubMed ID: 12798711
[TBL] [Abstract][Full Text] [Related]
13. Effect of the molecular targeted drug, erlotinib, against endometrial cancer expressing high levels of epidermal growth factor receptor.
Nishimura T; Nakamura K; Yamashita S; Ikeda S; Kigure K; Minegishi T
BMC Cancer; 2015 Dec; 15():957. PubMed ID: 26673416
[TBL] [Abstract][Full Text] [Related]
14. Relaxin, its receptor (RXFP1), and insulin-like peptide 4 expression through gestation and in placenta accreta.
Goh W; Yamamoto SY; Thompson KS; Bryant-Greenwood GD
Reprod Sci; 2013 Aug; 20(8):968-80. PubMed ID: 23302396
[TBL] [Abstract][Full Text] [Related]
15. Progestin suppresses matrix metalloproteinase production in endometrial cancer.
Di Nezza LA; Jobling T; Salamonsen LA
Gynecol Oncol; 2003 May; 89(2):325-33. PubMed ID: 12713999
[TBL] [Abstract][Full Text] [Related]
16. Relaxin deficiency results in increased expression of angiogenesis- and remodelling-related genes in the uterus of early pregnant mice but does not affect endometrial angiogenesis prior to implantation.
Marshall SA; Ng L; Unemori EN; Girling JE; Parry LJ
Reprod Biol Endocrinol; 2016 Mar; 14():11. PubMed ID: 27005936
[TBL] [Abstract][Full Text] [Related]
17. Effects of hepatocyte growth factor on the expression of matrix metalloproteinases and their tissue inhibitors during the endometrial cancer invasion in a three-dimensional coculture.
Park YH; Ryu HS; Choi DS; Chang KH; Park DW; Min CK
Int J Gynecol Cancer; 2003; 13(1):53-60. PubMed ID: 12631221
[TBL] [Abstract][Full Text] [Related]
18. [Expression and significance of Twist1 and MMP-2 in endometrial endometrioid adenocarcinoma].
Wang XJ; Chen XH
Zhonghua Zhong Liu Za Zhi; 2012 Aug; 34(8):588-91. PubMed ID: 23158991
[TBL] [Abstract][Full Text] [Related]
19. Evidence for expression of relaxin hormone-receptor system in the boar testis.
Kato S; Siqin ; Minagawa I; Aoshima T; Sagata D; Konishi H; Yogo K; Kawarasaki T; Sasada H; Tomogane H; Kohsaka T
J Endocrinol; 2010 Nov; 207(2):135-49. PubMed ID: 20807724
[TBL] [Abstract][Full Text] [Related]
20. Relaxin enhances the oncogenic potential of human thyroid carcinoma cells.
Hombach-Klonisch S; Bialek J; Trojanowicz B; Weber E; Holzhausen HJ; Silvertown JD; Summerlee AJ; Dralle H; Hoang-Vu C; Klonisch T
Am J Pathol; 2006 Aug; 169(2):617-32. PubMed ID: 16877360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
